Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:DD

DuPont de Nemours Inc. (DD)

136.70
+0.03 (0.02%)
as of Aug 25, 2026, 2:37:02 pm Market Open.
50 watching
0
Investor Insights
star iconAug 25, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

DuPont de Nemours Inc. has garnered a range of opinions from experts, particularly ahead of its upcoming earnings report. Notably, one expert highlights that the stock has experienced a parabolic rise, prompting them to sell some shares as a cautious approach to avoid greed. Despite this, the company's diverse business segments, particularly in water and materials, are praised for their robustness, and the CEO's leadership is acknowledged as commendable. A major point of interest is the anticipated split into two distinct entities—one focused on high-growth electronics and the other on stable sectors such as industrials, healthcare, and water. This strategic move is believed to enhance the overall value, with projections suggesting the stock could potentially reach $100 per share, which signifies a promising direction for DuPont.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
BASF, BAS
TOP PICK
Roughly 26% of sales come from the agricultural area. More and more, this company will be recognized as a player in the seed and pesticide area. Also doing great things with solar and specialized materials.
TOP PICK
Have 5 major operating areas. Agriculture and pesticides is one of the key areas to earnings.
HOLD
Chemical stocks in general are acting extremely well. They are late cycle players. If you are a long-term investor, this would be a stock you could own.
TOP PICK
Next year will come out with a new line of seeds. Seed business has been "growing" and will continue to accelerate.
TOP PICK
A dynamic applied research and technology firm. Production of seeds for corn, soybeans etc, which is taking "off like a rocket" Doing some amazing things with the coatings and materials area.
TOP PICK
There will be a massive shift in the dietary habits of emerging markets. He now has a 16% exposure to agriculture in his portfolios. This is one of the world's great applied research technology companies.
TOP PICK
A leader in high tech and innovative research. Immediate attraction is the agricultural area. There is increased demand for protein based foods in the Far East. Dupont is producing a very hardy seed that will be rolled out next year.
TOP PICK
A world leader in research and innovation. Likes their work on seeds for improvement of productivity. Doing a lot of work with bio-butanol. This will be a long-term hold.
TOP PICK
This one is cheap with a great ROE of 20%-25% a year. Good debt to capitalization ratio. This company is one of the most exciting plays in terms of the biotech field.
BUY
Of the chemical companies, this is the one he would probably own. Have a life sciences division that is starting to come to the fore as a % of revenues. Also coming out with new high fibre products that are starting to add incrementally to their earnings.
COMMENT
A 5-year chart would show a lot of ups and downs. Right now, there is clear resistance developing where stocks globally relating to commodities have made their peaks. Risk/reward does not look too favourable. If you own, you may want to sell your stocks and buy call options. At the very minimum, you should trail up a stop or buy a put to protect against the downside.
COMMENT
Strong institutional buying which is why the multiple is higher. Trying to add more life sciences to their business so there are more growth expectations built into the stock. Been on a bumpy ride because feedstock prices have been all over the place. Check the whole group and for every $1 change of natural gas, what do the earnings do? Gives you a better idea for the long-term.
WEAK BUY
Have quite an array of diverse products. He has a small weighting of this in his fund.
WEAK BUY
They have exposure to the rising input costs. On the other hand, they are world class company. If you feel global growth will accelerate, particularly out of Japan, it should be a good play, otherwise you shouldn’t be there.
BUY
Risk reward prespective we are there. Support on a short term basis. Much below $35 would be worried. Look at long term ranges.
Showing 106 to 120 of 124 entries